An estimated 252,710 women will be diagnosed with breast cancer in 2017.1 Early detection of breast cancer is critical for successful treatment of this disease - women who are diagnosed with early stage/localized breast cancer have a 5-year survival rate of 98.9% 1 We hope that this Breast Cancer Awareness Month will inspire more people to discuss…
Lynch syndrome is one of the most common hereditary cancer syndromes, affecting about 1/279-1/440 people in the U.S. It is caused by a genetic mutation in one of five genes: MLH1, MSH2, MSH6, PMS2, or EPCAM. Individuals with Lynch syndrome have a significantly increased lifetime risk for multiple types of cancer including colorectal…
In our quest to understand all human disease, Ambry employs a team of researchers who investigate topics from every area of genetics research. Throughout her tenure at Ambry, Zoe Powis, MS CGC, Supervisor of Clinical Genomics Research, has contributed much to the broader body of knowledge about the field of genetics. At this year’s National…
We present impactful research to move the science of genetics forward at tradeshow and conferences throughout the year. Check out some of the research, separated by category below, that we brought to this year’s National Society of Genetic Counselor’s annual meeting. Read about the contributions from our lead researcher Zoe Powis and the Ambry…
Just five short years ago, hereditary cancer testing was much simpler for patients and healthcare providers. There were finite criteria, associated with a handful of genetic conditions, and healthcare providers could order single-gene (or single-syndrome) genetic testing for patients who met those criteria. Since 2012, the field of genetics has…
An estimated 22,440 women will be diagnosed with ovarian cancer in 2017. Early detection is critical for successful treatment of this disease, which has a 5-year survival rate of 92.5% for women who are diagnosed with early stage/localized ovarian cancer.1 We hope that Ovarian Cancer Awareness Month will bring more women to their healthcare providers…
An estimated 161,360 men will be diagnosed with prostate cancer in 2017; early detection is critical for successful treatment of this disease. We hope that Prostate Cancer Awareness Month will bring more men to their healthcare providers asking about prostate cancer screening or about their risk of developing this disease. Genetic testing for…
At Ambry, we believe working together is better, that sharing data is essential to finding answers faster. Our scientists embody these beliefs by collaborating with other talented researchers and physicians to understand human disease, most recently in epilepsy genetics. We are proud to have contributed to the clinical research reviewed…
Germline genetic testing is used by many labs to evaluate a patient’s predisposition to hereditary cancer, and produces excellent results in its analysis of many genetic conditions. However, when germline testing is combined with tumor testing as a single paired test, it may yield even more helpful results in certain situations. Specifically,…
*Editor's Note: This post was originally shared on June 8th, 2016 and has been updated with current information. Learning the results of genetic testing can be a stressful experience for some, but it also has the potential to be empowering. If you are waiting for your genetic test results to come back or are considering…